v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net income $ 52,993 $ 50,612 $ 47,268
Reconciliations of net income to net cash provided by operating activities:      
Depreciation and amortization 7,601 7,110 6,228
Non-cash operating lease expense 6,470 7,036 6,955
Investment (accretion) amortization and (gains) losses recognized (221) 1,396 1,859
Losses recognized on disposal of property and equipment 65 256 139
Deferred income taxes (854) 4,626 (2,169)
Share-based compensation 8,840 8,465 7,390
Changes in certain operating assets and liabilities:      
Trade accounts receivable (63,126) (7,569) (8,131)
Income taxes 5,325 (8,597) (1,063)
Prepaid expenses and other (255) 1,344 (2,181)
Accounts payable 194 (1,671) 3,779
Accrued payroll and related benefits 55,170 5,698 12,219
Payroll taxes payable (23,465) 7,030 12,697
Other accrued liabilities (736) (4,177) 1,371
Premium payable 7,886 54,168 12,081
Workers' compensation claims liabilities (39,350) (51,246) (64,222)
Operating lease liabilities (6,668) (7,099) (6,740)
Other assets and liabilities, net 218 (160) 298
Net cash provided by operating activities 10,087 67,222 27,778
Cash flows from investing activities:      
Purchase of property, equipment and software (14,160) (11,827) (15,973)
Proceeds from sale of property and equipment 8 120  
Purchase of investments (7,902) (4,387)  
Proceeds from sales and maturities of investments 23,319 10,352 18,732
Purchase of restricted investments (29,971) (66,734) (4,345)
Proceeds from sales and maturities of restricted investments 67,491 17,289 62,740
Net cash provided by (used in) investing activities 38,785 (55,187) 61,154
Cash flows from financing activities:      
Proceeds from credit-line borrowings 415 12,313  
Payments on credit-line borrowings (415) (12,313)  
Payments on long-term debt     (3,510)
Repurchase of common stock (29,133) (34,192) (47,168)
Common stock repurchased on vesting of stock awards (4,837) (2,993) (1,692)
Dividends paid (8,086) (8,089) (8,524)
Proceeds from exercise of stock options and purchase of ESPP 931 702 711
Net cash used in financing activities (41,125) (44,572) (60,183)
Net increase (decrease) in cash, cash equivalents and restricted cash 7,747 (32,537) 28,749
Cash, cash equivalents and restricted cash, beginning of period 74,841 107,378 78,629
Cash, cash equivalents and restricted cash, end of period $ 82,588 $ 74,841 $ 107,378

Source